These FOXM1 binding data were collected from 6 studies across 8 different cell lines (Table 1), including MCF-7 (ER-positive breast cancer), MDA-MB-231 (ER-negative breast cancer), ECC-1 (endometrium cancer), GM12878 (blood), HEK293 (kidney cancer), HeLa (cervical cancer), SK-N-SH (neuroblastoma), and U2OS (osteosarcoma). This evidence concerns the gene FOXM1 and osteosarcoma.